New Implications for CABG: Perspectives from Latin America, Europe, Canada, and the US

Co-presented by STS, the European Association for Cardio-Thoracic Surgery (EACTS), and the Latin American Association of Cardiac and Endovascular Surgery (LACES)

An international panel of experts reviewed recent trials leading to new and controversial guidelines for coronary revascularization and the implications these might have on clinical practice, referral patterns, and reimbursement. Moderators Victor Dayan, MD, and J. Rafael Sádaba, MD, PhD, FRCS CTh, led a discussion following presentations on the FAME3 trial, ISCHEMIA trial, and recent ACC/AHA/SCAI Guideline for Coronary Artery Revascularization, with special attention to Latin American and European perspectives.

Agenda
9:00 a.m. – 9:12 a.m. ET FAME3 Trial
Filip P.A. Casselman, MD, PhD, FETCS, Aalst, Belgium
9:12 a.m. – 9:24 a.m. ET ISCHEMIA Trial
William E. Boden, MD, Boston, MA
9:24 a.m. – 9:36 a.m. ET ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Joseph F. Sabik III, MD, Cleveland, OH
9:36 a.m. – 9:48 a.m. ET European Guidelines
Patrick O. Myers, MD, Lausanne, Switzerland
9:48 a.m. – 10:00 a.m. ET The LACES Perspective
Rui M.S. Almeida, MD, PhD, Cascavel, Brazil
10:00 a.m. – 10:30 a.m. ET Discussion

Learning Objectives

At the end of this activity, participants should be able to:

  • Understand the updated ACC/AHA and European guidelines for coronary revascularization. 

  • Describe the guidelines’ implications on clinical practice management.

Certificates of participation will be available, but no continuing medical education credit will be offered.

The program will be presented in English, with simultaneous translation in Spanish. 

It’s free to attend, but registration is required. Zoom credentials will be shared with registrants in the week of the meeting. 

Questions? Contact the STS Education department.